James B. Hawkins is Director at IRADIMED CORP (IRMD). They have made 64 open-market trades across 7 companies since 2006, most recently 2026-08-20.
CIK 0000898243
28 open-market purchases totalling $4.6M since 2007, against 36 sales. Across 28 scored buys the stock is down 2.4% at ninety days, and 4.8 points behind the S&P over the same stretch.
28 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 50% | 32% |
| Avg Move | -0.5% | +3.2% | -2.4% |
| Alpha | +1.1% | +2.6% | -4.8% |
| Scored | 28 | 28 | 28 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AEYE | BUY | 2026-03-10 | 2026-03-12 | $5.78 | $220K | -8.6% | +7.5% | +13.5% |
| IRMD | SELL | 2025-12-09 | 2025-12-10 | $96.61 | $290K | -0.5% | +1.4% | +1.4% |
| AEYE | BUY | 2025-11-20 | 2025-11-24 | $11.33 | $45K | +12.2% | -7.9% | -43.8% |
| IRMD | SELL | 2025-11-20 | 2025-11-21 | $88.23 | $333K | +4.7% | +8.3% | +12.4% |
| AEYE | BUY | 2025-11-17 | 2025-11-19 | $11.49 | $46K | +2.0% | -8.4% | -44.6% |
| AEYE | BUY | 2025-11-13 | 2025-11-13 | $11.90 | $71K | +4.7% | +3.5% | -39.6% |
| AEYE | BUY | 2025-11-11 | 2025-11-12 | $12.58 | $101K | -6.4% | +0.4% | -39.7% |
| OSIS | SELL | 2025-11-07 | 2025-11-07 | $283.15 | $849K | -16.9% | -8.2% | -9.8% |
| AEYE | BUY | 2025-08-18 | 2025-08-19 | $10.95 | $88K | +13.0% | +19.9% | +2.5% |
| AEYE | BUY | 2025-03-19 | 2025-03-21 | $15.39 | $205K | -1.4% | -9.2% | -2.0% |
| OSIS | SELL | 2024-12-10 | 2024-12-12 | $182.62 | $365K | -5.9% | -17.5% | -3.0% |
| OSIS | SELL | 2024-05-08 | 2024-05-09 | $134.09 | $2.7M | +6.6% | +1.5% | +0.7% |
| IRMD | SELL | 2023-12-12 | 2023-12-14 | $43.88 | $647K | +2.2% | -2.6% | -2.2% |
| IRMD | SELL | 2023-12-01 | 2023-12-05 | $43.02 | $820K | +7.0% | +7.4% | -1.6% |
| IRMD | SELL | 2022-02-15 | 2022-02-17 | $50.22 | $948K | +10.0% | +8.3% | -32.4% |
| IRMD | SELL | 2021-12-07 | 2021-12-09 | $47.09 | $1.8M | -3.8% | -4.2% | +4.4% |
| IRMD | SELL | 2021-11-26 | 2021-11-30 | $45.83 | $1.4M | -1.0% | +0.1% | +9.2% |
| IRMD | SELL | 2021-11-23 | 2021-11-24 | $42.71 | $3.7M | +10.4% | +7.8% | +7.3% |
| IRMD | SELL | 2021-11-05 | 2021-11-10 | $38.67 | $1.2M | +10.0% | +19.4% | +39.7% |
| IRMD | SELL | 2021-11-02 | 2021-11-05 | $38.17 | $2.6M | +1.9% | +16.1% | +2.2% |
| IRMD | SELL | 2021-08-09 | 2021-08-11 | $35.48 | $1.1M | -4.8% | -2.0% | +7.8% |
| ERI | BUY | 2019-09-03 | 2019-09-03 | $35.70 | $71K | +17.4% | +6.7% | +43.1% |
| ERI | BUY | 2019-08-08 | 2019-08-12 | $40.35 | $242K | +0.2% | +6.6% | +28.9% |
| ERI | BUY | 2018-09-05 | 2018-09-05 | $46.50 | $47K | +0.1% | -6.8% | -14.3% |
| ERI | BUY | 2018-08-07 | 2018-08-07 | $42.45 | $170K | +6.7% | +6.4% | -14.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| IRIX |
| 31,294 |
| $27K |
| Total | $30.1M |
Shares reported on the most recent Form 4, priced at the 2026-08-21 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.